Lexeo Therapeutics (LXEO) Cash & Current Investments (2022 - 2023)
Historic Cash & Current Investments for Lexeo Therapeutics (LXEO) over the last 2 years, with Q3 2023 value amounting to $35.4 million.
- Lexeo Therapeutics' Cash & Current Investments fell 6234.96% to $35.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $35.4 million, marking a year-over-year decrease of 6234.96%. This contributed to the annual value of $77.3 million for FY2022, which is N/A changed from last year.
- Per Lexeo Therapeutics' latest filing, its Cash & Current Investments stood at $35.4 million for Q3 2023, which was down 6234.96% from $77.3 million recorded in Q4 2022.
- In the past 5 years, Lexeo Therapeutics' Cash & Current Investments ranged from a high of $94.2 million in Q3 2022 and a low of $35.4 million during Q3 2023